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Abstract  
The Stewart-Treves syndrome was first described in 1948, it's an angiosarcoma developed on a longstanding lymphadenomatous limb, more often 
after radical mastectomy. Diagnosis is made on skin biopsy and the prognosis is poor when radical surgery can't be performed. We report the case 
on a Stewart-Treves syndrome in a sixty-six years old woman who underwent radical mastectomy for breast carcinoma ten years earlier. Surgery 
was not feasible at the time of diagnosis, and we lost touch of the patient even if chemotherapy was decided. Radical surgery is the best treatment 
to date for this rare disease. Conservative surgery with adjuvant radiotherapy is also possible. Systemic chemotherapy is reserved for locally 
advanced unresectable and metastatic forms. We advocate long term follow-up for every post mastectomy lymphedema to diagnosis this fatal 
disease when curable. 
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Introduction 
 
Stewart-Treves syndrome is an angiosarcoma developed from 
longstanding lymphedema due to axillary lymph node dissection 
following a radical mastectomy. It was first reported by Stewart and 
Treves in 1948 [1]. In their study, they reported a series of six 
patients who had developed angiosarcoma in their lymphedematous 
extremities after radical mastectomy. The controversy persisted for 
the exact mechanism of Stewart-Treves syndrome; some authors 
have favored the hypothesis of epithelial skin metastases of breast 
cancer Treaty, as amended by stromal edema environment [2, 3]. 
But the presence of a vascular proliferation tumor associated with 
the appearance of antifactor VIII positive sign the original 
angiosarcomatosis . In addition, the Stewart-Treves syndrome has 
not only been described in post mastectomy, it can be post 
radiotherapy, congenital, post trauma or post burn. 
  
  
Patient and observation 
 
We report the case of a sixty-six years old woman who underwent 
radical mastectomy for breast carcinoma ten years earlier. She was 
complaining of chronic lymphedema of the left arm five years ago 
and developed on this lymphoedema, cutaneous lesions (Figure 
1,Figure 2) that extended to the chest wall and was not accessible 
to a radical surgery. Skin biopsy confirmed the diagnosis of 
angiosarcoma. No metastasis were found elsewhere. A treatment by 





The Stewart-Treves syndrome was first described by Fred Stewart 
and Norman Treves in 1948, they reported six cases of 
angiosarcoma that arose from areas of lymphedema as a 
consequence of mastectomy. Today, there are over 400 cases of 
Stewart-Treves reported in the literature .The prevalence is 
estimated at approximately 0.45% in patients who survive longer 
than five years after a mastectomy [4]. The incidence has been 
decreasing recently, most likely due to changes in operative therapy 
and radiotherapy in breast cancer. Conservative surgery to minimize 
loss of breast tissue, coupled with less axillary radiation treatment, 
have led to a reduction in chronic lymphedema to as low as 4%. 
This decreasing has also been aided by the advent of sentinel lymph 
node biopsy. 
  
The Stewart-Treves syndrome is characterized clinically by the 
occurrence, at a lymphadenomatous member of tumor infiltrating 
lesions, nodules, often multiple and purple, painless, rarely 
ulcerated. The series of Woodward et al. [5], recording 162 cases of 
lymphangiosarcomas after mastectomy, helped to better define their 
natural history. The onset is usually late, an average of 10 years 
and 3 months after mastectomy, with extremes ranging from 1 to 
26 years. The involvement of adjuvant breast irradiation remains 
unclear in the pathogenesis of Stewart-Treves syndrome after 
mastectomy. However, the practice of axillary irradiation after an 
axillary lymph node dissection is well-known to increase the risk of 
post-treatment lymphoedema. Thereby reducing the incidence of 
Stewart-Treves syndrome involves to better define the indication of 
adjuvant radiotherapy for breast cancer. Furthermore, Woodward et 
al. [5] noted the frequent association (9-19%) to a third cancer, 
most frequently gynecological. In the absence of any specific 
treatment, the prognosis of Stewart-Treves syndrome remains dark, 
with a median survival of a few months. Its spontaneous evolution 
is characterized by major tumor aggressiveness responsible of 
locoregional extension by contiguity to the limb and chest wall, 
associated with metastatic extension represented by the lungs. 
  
The underlying pathophysiology of this disease is still debated. It is 
postulated that lymphatic blockage encourages the growth of 
lymphatic vessels through growth factors and cytokines. This is 
demonstrated by the fact that there is lymphatic vessel proliferation 
in unaffected areas of the limb [4]. Histological examination with an 
optical microscope [6] commonly found within a stromal edema, a 
nodular tumor proliferation, consisting blanks pace vascular cavities, 
consisting of many carriers endothelial cell atypia. The vascular and 
conjunctiva nature of these tumors is confirmed by 
immunohistochemistry, with positive staining for laminin, antibodies 
against factor VIII, type IV collagen and CD31[7]. Negativity of 
epithelial differentiation markers (EMA, cytokeratin) finally 
eliminates the main differential diagnosis, consisting of cutaneous 
metastases of breast cancer. High level gene amplification of MYC is 
also a distinguishing feature of cutaneous secondary angiosarcomas, 
which develops after chronic lymphoedema or irradiation. This is in 
contrast to primary angiosarcomas, which tend to be present deep 
in soft tissue and do not have high MYC gene amplification [8]. 
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The scarcity of Stewart-Treves syndrome explains the absence of 
therapeutic strategy. Treatment of this syndrome is difficult as 
angiosarcomas are all high grades, and typically metastasise to the 
lungs and chest wall. In localized forms, the respective roles of 
surgery, radical or not, local radiotherapy or a combination of both 
are not precisely determined. The choice of treatment will depend 
on prognosis of the breast tumor underlying this disease and wishes 
of the patient. Patients who are treated with amputation rather than 
radiotherapy have a better prognosis. Despite of this, their overall 
survival remains very poor with a survival range of 5-8 months [9]. 
Systemic chemotherapy is reserved for locally advanced 
unresectable and metastatic forms. Although its therapeutic benefit 
is little studied, few cytotoxic drugs have indeed been evaluated, 
including anthracyclines and ifosfamide who are the major drugs in 
soft tissue sarcoma. Two Japanese teams [10] have reported result 
of active immunotherapy with recombinant interleukin 2 (IL2). The 
case is a 76 years old woman who developed angiosarcoma on 
chronic lymphoedema 11 years after mastectomy treated by local 
and systemic injections of recombinant IL2, the patient lived 16 





The stewart-Treves syndrome is an angiosarcoma developed on a 
lymphadenomatous limb, most frequently after radical mastectomy 
and axillary dissection. The prognosis is very poor, but one should 
not be nihilistic. We advocate continuous follow-up for every post 
mastectomy lymphedema with skin biopsy of every suspicious 
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Figure 1 : angiosarcoma extending on the chest wall 
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Figure 2 : Stewart-Treves syndrome of the left arm 
 
